CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 1 filers reported holding CUREVAC N V in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,000 | -26.1% | 17,069 | +13.2% | 0.00% | – |
| Q2 2023 | $157,000 | +72.5% | 15,085 | +15.7% | 0.00% | – |
| Q1 2023 | $91,000 | +313.6% | 13,043 | +248.5% | 0.00% | – |
| Q4 2022 | $22,000 | -74.7% | 3,743 | -66.3% | 0.00% | – |
| Q3 2022 | $87,000 | -34.6% | 11,119 | +13.0% | 0.00% | – |
| Q2 2022 | $133,000 | -45.3% | 9,839 | -20.6% | 0.00% | – |
| Q1 2022 | $243,000 | -46.4% | 12,399 | -6.2% | 0.00% | – |
| Q4 2021 | $453,000 | +33.6% | 13,217 | +114.0% | 0.00% | – |
| Q3 2021 | $339,000 | +153.0% | 6,176 | +237.9% | 0.00% | – |
| Q2 2021 | $134,000 | +191.3% | 1,828 | +260.6% | 0.00% | – |
| Q1 2021 | $46,000 | -83.6% | 507 | -85.3% | 0.00% | – |
| Q4 2020 | $280,000 | +76.1% | 3,441 | +1.2% | 0.00% | – |
| Q3 2020 | $159,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $171,200,000 | 50.12% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 61,100 | $3,337,000 | 0.35% |
| Renaissance Capital LLC | 25,454 | $1,390,000 | 0.28% |
| Green Alpha Advisors, LLC | 5,170 | $282,000 | 0.20% |
| Caption Management, LLC | 304,400 | $16,626,000 | 0.19% |
| Paradigm Financial Advisors, LLC | 14,009 | $765,000 | 0.18% |
| Baillie Gifford | 3,940,731 | $215,243,000 | 0.11% |
| MANGROVE PARTNERS IM, LLC | 20,200 | $1,103,000 | 0.10% |
| MANGROVE PARTNERS IM, LLC | 20,200 | $1,103,000 | 0.10% |
| Ergoteles LLC | 43,358 | $2,368,000 | 0.09% |